Amdocs (NASDAQ:DOX) Stock Rating Upgraded by StockNews.com

Amdocs (NASDAQ:DOX) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a report released on Monday.

A number of other research firms also recently commented on DOX. Oppenheimer upped their price objective on Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. Stifel Nicolaus assumed coverage on shares of Amdocs in a research report on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 price target on the stock. Finally, Barclays cut their target price on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a report on Thursday, November 14th. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Amdocs has an average rating of “Buy” and an average target price of $101.20.

Amdocs Trading Up 0.4 %

NASDAQ DOX traded up $0.30 during trading hours on Monday, hitting $84.47. The company’s stock had a trading volume of 447,688 shares, compared to its average volume of 486,263. The stock has a fifty day moving average of $87.03 and a 200 day moving average of $85.57. The company has a quick ratio of 1.24, a current ratio of 1.20 and a debt-to-equity ratio of 0.21. Amdocs has a twelve month low of $74.41 and a twelve month high of $94.04. The firm has a market capitalization of $9.54 billion, a P/E ratio of 19.92, a PEG ratio of 1.45 and a beta of 0.71.

Institutional Trading of Amdocs

A number of institutional investors have recently modified their holdings of the company. Private Trust Co. NA lifted its stake in Amdocs by 62.9% in the 3rd quarter. Private Trust Co. NA now owns 303 shares of the technology company’s stock valued at $27,000 after acquiring an additional 117 shares in the last quarter. Brooklyn Investment Group acquired a new stake in shares of Amdocs in the third quarter valued at approximately $28,000. Catalyst Capital Advisors LLC bought a new stake in shares of Amdocs in the third quarter worth $55,000. GAMMA Investing LLC boosted its holdings in Amdocs by 115.1% during the third quarter. GAMMA Investing LLC now owns 800 shares of the technology company’s stock worth $70,000 after purchasing an additional 428 shares during the last quarter. Finally, Meeder Asset Management Inc. bought a new position in Amdocs in the third quarter valued at $77,000. 92.02% of the stock is currently owned by institutional investors.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.